Insulin Glargine Market Growth Accelerated by Growing Burden of Diabetes Mellitus

 


Insulin glargine is a long-acting basal human insulin analog used for the treatment of diabetes mellitus. It has a protracted duration of action of over 24 hours after single daily administration and provides effective improvement in glycemic control along with low risk of hypoglycemia compared to intermediate-acting human insulin. The global Insulin Glargine Market is estimated to be valued at US$ 1.68 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The rising prevalence of diabetes across the globe has accelerated the adoption of insulin therapy. According to the International Diabetes Federation, approximately 537 million adults aged 20-79 years were living with diabetes in 2021, and this number is expected to rise to 643 million by 2030 and 783 million by 2045. Insulin glargine is one of the key drugs used for the treatment of diabetes. Therefore, the growing burden of diabetes mellitus has significantly fueled the demand for insulin glargine over the recent years.

Segment Analysis

The Global Insulin Glargine Market Size is dominated by the prefilled syringe sub-segment. Prefilled syringes are easy-to-use and convenient, as they eliminate the need for drawing insulin from a vial. This reduces the risk of dosing errors. Prefilled syringes also allow for accurate dosing of insulin compared to vials. Due to these advantages, prefilled syringes are the preferred choice among healthcare providers and insulin-dependent patients.

Key Takeaways

The global insulin glargine market is expected to witness high growth over the forecast period of 2024 to 2031. The market is projected to reach a value of US$ 1.68 Bn by 2024, expanding at a CAGR of 19%.

Regional analysis: Europe currently dominates the global insulin glargine market. Countries in Europe have a high prevalence of diabetes, improved access to healthcare, and governments that provide partial to full reimbursement for diabetic drugs and devices. However, the Asia Pacific region is expected to be the fastest-growing market during the forecast period. Rapid economic development, growing geriatric population, increasing obesity rates and sedentary lifestyles are fueling the demand for insulin glargine in Asia Pacific countries.

Key players: Key players operating in the insulin glargine market are Siemens Healthineers, Mckesson Corporation, IBM Corporation, Genpact Limited, Epic Systems Corporation, Deloitte, Cerner Corporation, Accenture Plc, Allscripts Healthcare Solutions Inc., and Cognizant Technology Solutions Corporation, among others. Allscripts Healthcare Solutions Inc. offers an insulin glargine biosimilar called Basaglar, which is co-developed with Eli Lilly. Accenture Plc provides strategic advisory, implementation and managed services to life sciences players including those dealing in insulin glargine.

 

Get More Insights On This Topic: https://www.newsstatix.com/insulin-glargine-market-size-share-analysis-2023-2030/


Comments

Post a Comment

Popular posts from this blog

Macrophage Marker Market Poised to Grow at a Robust Pace Due to Rising Demand in Medical Diagnostics

Image
  The macrophage marker market has witnessed significant growth in recent years owing to the growing applications of macrophage markers in medical diagnostics. Macrophage markers are proteins or cell surface receptors that are expressed by macrophages and are used to identify and study macrophages and their functions. Some of the key macrophage markers include CD14, CD68, CD163, CD206, and LAMP-3. These markers play a vital role in studying the functions of macrophages in various diseases like cancer, inflammatory disorders, and infectious diseases. The global macrophage marker market is estimated to be valued at US$ 295.15 million in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period of 2024-2030. The growing prevalence of various chronic and infectious diseases and increase in R&D spending for drug discovery are some of the key factors driving the demand for macrophage markers in recent years. Macrophage markers help in evaluating disease progression, d...
Read more

The Global Boat Accumulator Market Growth Is Accelerated By Increasing Consumer Spending

Image
  Boat accumulators or batteries are sealed lead acid batteries that provide starting power and deep cycle power for boats. They are essential for powering marine electrical systems, motors, navigation lights, bilge pumps and other onboard appliances. The growing marine tourism and recreational boating activities have increased the demand for boats and yachts over the years. This has propelled the boat accumulator market. The global Boat Accumulator Market is estimated to be valued at US$ 266.66 Mn in 2023 and is expected to exhibit a CAGR of 2.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing consumer spending on recreational boating activities has been a major driver for the boat accumulator market over the past decade. The number of recreational boats sold globally has increased steadily with the rise in disposable incomes and leisure time among consumers. Countries like the United S...
Read more

Growth Accelerated by Rising Demand from Biomedical Research and Clinical Diagnostics

Image
  Chemiluminescence imaging is widely used technique for the detection of biomolecules. The technique offers advantages such as high sensitivity, minimal sample requirement and less incubation time. Chemiluminescence assays find wide application in various research areas such as oncology research, infectious disease research and reproductive health among others. Moreover, clinical diagnostics of conditions like cancer, liver disorders also rely on chemiluminescence technique for detection of biomarkers. Growing incidence of chronic diseases is propelling the demand for clinical diagnostic testing, thus favoring the growth of chemiluminescence imaging market. The global Chemiluminescence Imaging Market is estimated to be valued at US$ 13.2 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Rising demand from biomedical research and clinical diagnos...
Read more